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Background: Lactic acid is a byproduct of both muscle metabolism and the central nervous
system. Changes in metabolism are related to various physiological and pathological con-
ditions. The aim of this study was to determine the relationship between migraine and
ﬁbromyalgia with the levels of lactic acid in the blood.
Methods: We  study 93 patients divided into ﬁve groups: (1) patients with ﬁbromyalgia (n = 20);
(2)  episodic migraine (n = 20); (3) chronic migraine (n = 20); (4) ﬁbromyalgia and episodic
migraine (n = 13); and (5) ﬁbromyalgia and chronic migraine (n = 20), and 20 healthy sub-
jects  (control group). Blood levels of lactic acid were measured at four different time points:
at  rest, during aerobic exercise, during anaerobic physical activity and while resting after
anaerobic exercise.
Results: Lactic acid increased in all groups during anaerobic physical activity without pre-
dominance for either group. During aerobic physical activity, all groups increased lactic acid
levels, but the increase was more expressive in the chronic migraine group and the chronic
migraine with ﬁbromyalgia group without statistical signiﬁcance.
Conclusions: We  did not found abnormalities involving the metabolism of lactic acid inepisodic and chronic migraine with or without ﬁbromyalgia.© 2015 Elsevier Editora Ltda. All rights reserved.
 The study was conducted at the Neurology, Cardiology and Rheumatology Services, Hospital de Clínicas, Universidade Federal do
araná (UFPR), Curitiba, PR, Brazil.
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A  importância  de  ácido  láctico  na  enxaqueca  e  na  ﬁbromialgia
Palavras-chave:
Enxaqueca crônica
Enxaqueca episódica
Ácido láctico
Fibromialgia
r  e  s  u  m  o
Introduc¸ão: O ácido láctico é um subproduto do metabolismo muscular e do sistema nervoso
central. As alterac¸ões no metabolismo estão relacionadas com diversas condic¸ões ﬁsiológ-
icas  e patológicas. O objetivo deste estudo foi determinar a relac¸ão entre a enxaqueca e a
ﬁbromialgia com os níveis de ácido láctico no sangue.
Métodos: Foram estudados 93 pacientes, divididos em cinco grupos: 1) ﬁbromialgia (n = 20);
2)  enxaqueca episódica (n = 20); 3) enxaqueca crônica (n = 20); 4) ﬁbromialgia e enxaqueca
episódica (n = 13); e 5) ﬁbromialgia e enxaqueca crônica (n = 20), além de 20 indivíduos
saudáveis (grupo controle). Os níveis sanguíneos de ácido láctico foram medidos em quatro
momentos: em repouso, durante o exercício aeróbico, durante a atividade física anaeróbica
e  durante o descanso depois do exercício anaeróbico.
Resultados: O ácido láctico aumentou em todos os grupos durante a atividade física
anaeróbica, sem predominância em qualquer grupo. Durante a atividade física aeróbica,
todos os grupos apresentaram um aumento nos níveis de ácido láctico, mas esse aumento
foi  mais expressivo nos grupos de enxaqueca crônica e enxaqueca crônica com ﬁbromialgia,
sem signiﬁcância estatística.
Conclusões: Não foram encontradas anormalidades que envolvessem o metabolismo do
ácido láctico na enxaqueca episódica e crônica, na presenc¸a ou não de ﬁbromialgia.
© 2015 Elsevier Editora Ltda. Todos os direitos reservados.Introduction
Migraine is a chronic neurological disorder with high preva-
lence and severe impact on a patient’s quality of life. This
disorder has genetic characteristics that modulate a dysfunc-
tion in brain electrical activity. This neurological condition is
characterized by recurrent episodes of headache with unilat-
eral throbbing characteristics of moderate to strong severity
that worsens with physical activity. This worsening is associ-
ated with vomiting, nausea, phonophobia and photophobia.1,2
Many  biochemical changes can be observed during and
between migraine attacks. Lactic acid levels, for example, may
be altered, exhibiting an increase compared with patients
with tension-type headache and healthy controls.3 These
data suggest that migraine patients have an abnormality in
mitochondrial metabolism. It was demonstrated that lactate
levels within the visual occipital cortex is elevated in migraine
patients during the inter-ictal period and could suggest the
presence of anaerobic glycolysis in cortical regions.4 However,
other studies have not conﬁrmed these changes and, as a
result, do not support this hypothesis.5
Lactic acid usually increases during high-intensity physical
activity and is related to a decline in muscle strength and pain
generation during exercise.6–8 Additionally, the increase in lac-
tic acid observed during exercise has been shown to trigger
migraine attacks with aura.9,10 Despite this causal relation-
ship, lactic acid is not considered an algogenic substance.11
Fibromyalgia is a chronic pain condition of unknown
etiology characterized by widespread spontaneous muscle
pain and tenderness to palpation. The diagnostic criteria
used for ﬁbromyalgia comes from the American College of
Rheumatology 2009 and 2010.12,13 Fibromyalgia can also dis-
play co-morbidities, such as psychiatric disorders and otherpain syndromes. The correlation between ﬁbromyalgia and
migraine varies from 22 to 50% of cases.14 This association
contributes to a decreased quality of life for patients and
enhances the presence of co-morbidities. The pathophysio-
logical relationship between these two disorders has not yet
been established in the medical literature.
Patients with ﬁbromyalgia may experience high levels of
lactic acid at rest15,16 or during aerobic physical activity.17
However, other studies show that changes in glycolysis and
lactic acid at rest or during physical activity were slight
increased among ﬁbromyalgia patients.18,19
The ratio of lactic acid production in patients with migraine
and ﬁbromyalgia, as well as the inﬂuence of this metabolite
in the pathophysiology of these diseases, is controversial or
nonexistent. The goal of this study is to determine whether
the metabolism of lactic acid changed in episodic migraine or
chronic migraine, with or without associated ﬁbromyalgia.
Patients  and  methods
We selected from out-patient headache clinic cases with
chronic and episodic migraine who were also suffering from
ﬁbromyalgia and from the out-patient rheumatology clinic
for patients with only ﬁbromyalgia. All patients with chronic
and episodic migraine met  the criteria proposed by the
International Headache Society Classiﬁcation (IHS-2004).2 The
ﬁbromyalgia patients fulﬁlled all of the criteria of the Ameri-
can Society of Rheumatology (2009 version).13 For the control
group, we  recruited employees belonging to the clinical staff
of the Hospital de Clínicas da Universidade do Paraná. All
patients and controls underwent a clinical and laboratory
investigation to rule out silent diseases, such as diabetes, kid-
ney failure, liver disease, lung disease and heart disease.
 . 2 0 1
M
A
l
(
t
(
a
(
a
b
i
c
m
S
T
t
m
h
m
s
E
T
m
t
e
e
i
b
w
a
a
s
a
5
m
w
s
3
L
L
t
p
o
(
b
B
(
m
E
A
dr e v b r a s r e u m a t o l
edications
 portion of patients continuously used one or more  of the fol-
owing medications: selective inhibitors of serotonin uptake
n = 23), tricyclic antidepressants (n = 20), selective recep-
or of serotonin inhibitors, norepinephrine and dopamine
n = 5), antipsychotics/dopamine blockers (n = 6), benzodi-
zepines (n = 14), sleep inducers (n = 1), muscle relaxants
n = 19), anti-inﬂammatory drugs (n = 9), antimalarials (n = 2),
ntihistamines for allergy (n = 4), statins (n = 3), proton pump
lockers (n = 6), anticonvulsants (n = 10), angiotensin convert-
ng enzyme inhibitors (n = 10), diuretics (n = 10), oral anti-
oagulants (n = 1), alendronate (n = 1), levothyroxine (n = 15),
etformin, insulin and orlistat (n = 4).
ymptoms  during  testing
he tests were performed despite the painful muscle symp-
oms in patients with ﬁbromyalgia. The patients with episodic
igraine underwent the test only if they were free of a
eadache crisis for at least ﬁve days. Patients with chronic
igraine were tested during periods of lower headache inten-
ity.
xercise  stress  testing
he patients underwent exercise stress testing using a tread-
ill with progressive increments of effort and while using
he software MicromedErgoPC 13. Initially, the patients had an
lectrocardiogram at rest (baseline control phase) followed by
xercises with a mean duration of 30 min. The treadmill was
n a ﬂat position, started at speeds of 2.0 mph  and increased
y 1.0 mph  every minute until reaching 9.0 mph. The test
as divided into different stages: aerobic, anaerobic exercise
nd rest post exercise. To differentiate between aerobic and
naerobic exercise, we  used the Karvonen formula (220 minus
ubject age = maximum heart rate for the age). We considered
erobic metabolic activity when the heart rate was between
0 and 69% of the predicted value found in the Karvonen for-
ula for the age and anaerobic exercise when the heart rate
as from 70% to 85% of the predicted maximum. All subjects
ustained the exercise at the necessary heart rate for at least
 min.19 All subjects were considered to be sedentary.
actic  acid  determination
actic acid was determined by capillary blood samples via a
ransdermal skin punch of the left index ﬁnger at four time
oints: (1) resting baseline before exercise; (2) after 10 min
f aerobic activity; (3) after 3 min  of anaerobic activity; and
4) after 6 min  of rest following anaerobic exercise. A drop of
lood was placed on a speciﬁc paper tape (Roche Diagnostics
razil) and introduced into a device for reﬂectance photometry
Accutrend Lactate, Roche Diagnostica, Brazil), which auto-
atically determined the levels of lactic acid.thics  study
ll patients signed an informed consent form. The proce-
ures in this study were approved by the ethics committee 5;5 5(6):471–476 473
for human research at the Hospital de Clinicas, Universidade
Federal do Paraná.
Statistical  analysis
In addition to descriptive statistical tests, we  used the t-test
for independent samples (homogenization of cases) and the
Mann–Whitney U test for making comparisons between the
levels of lactic acid in the various stages of the study (p < 0.05
for statistical signiﬁcance). To conﬁrm the results we  applied
the Bonferroni correction. Statistical analysis and plots were
done using the SPSS software version 11.0 (Chicago, IL).
Results
Study  subjects
The study subjects were grouped by age, weight, height and
body mass index (BMI). All subjects and controls were females.
Patients were divided into six groups: Group I – the healthy
subjects using no medication (n = 20); Group II – patients
with only ﬁbromyalgia (n = 20); Group III – patients with only
episodic migraine (n = 20); Group IV – patients with only
chronic migraine (n = 20); Group V – patients with ﬁbromyal-
gia plus episodic migraine (n = 13); and Group VI – patients with
ﬁbromyalgia plus chronic migraine (n = 20) (Table 1). All groups
were similar, and there was no statistically signiﬁcant differ-
ence between them with respect to age, weight, height or body
mass index (BMI) (Table 1).
Lactic  acid  blood  levels
The lactic acid was measured in 113 cases in four occasions
(452 analyses): the baseline phase, aerobic phase, anaero-
bic phase and rest after physical activity. The lactic acid
average of all groups underwent elevation during anaer-
obic activity and remained high during the rest period.
Comparison of all subjects lactic acid level at the base-
line phase (2.70 ± 1.32 mmol/L) with the anaerobic phase
(3.81 ± 1.81 mmol/L) showed a signiﬁcant increase (p = 0.0001).
The lactic acid level at the baseline phase compared with
the post-exercise rest (3.28 ± 1.34 mmol/L) was also signiﬁ-
cant (p = 0.001). The aerobic phase lactic acid also increased
(3.01 ± 2.20 mmol/L) but was not signiﬁcantly different from
the baseline (p = 0.125) (Fig. 1).
No signiﬁcant difference was found between aerobic
exercises when compared with the baseline phase in all
groups. Anaerobic exercise increased the lactic acid compared
with baseline in the control group (p = 0.0001), ﬁbromyalgia
group (p = 0.0001) and chronic migraine group (p = 0.008). In
the post-exercise rest group, the lactic acid remained ele-
vated in the control group (p = 0.008) and the ﬁbromyalgia
group (p = 0.003). In the groups of episodic migraine, chronic
migraine, ﬁbromyalgia plus episodic migraine and chronic
migraine plus ﬁbromyalgia, the levels of lactic acid remained
slightly elevated or near the basal control without statistical
signiﬁcance (Table 2).
When the levels of lactic acid were compared among the
groups, the variation was not statistically signiﬁcant between
474  r e v b r a s r e u m a t o l . 2 0 1 5;5 5(6):471–476
Table 1 – Subjects characteristics of the controls, ﬁbromyalgia and migraine cases.
Group Number of casesa Age (years-old)
Mean ± SD
Min–max
Weight (kg)
Mean ± SD
Min–max
Height (m)
Mean ± SD
Min–max
Body index
mass
Mean ± SD
Min–max
Controls 20 42.60 ± 9.36
(22–56)
66.75 ± 9.15
(53–84)
1.64 ± 0.76
(1.53–1.80)
24.95 ± 3.90
(18.59–34.17)
Fibromyalgia 20 47.35 ± 6.33
(32–57)
65.75 ± 12.38
(46–90)
1.60 ± 0.54
(1.49–1.70)
25.65 ± 4.98
(18.81–34.07)
Episodic migraine 20 37.75 ± 10.54
(21–59)
65.95 ± 12.68
(46–90)
1.62 ± 0.67
(1.50–1.76)
25.24 ± 5.21
(17.85–35.15)
Chronic migraine 20 39.15 ± 12.13
(26–67)
65.15 ± 11.88
(45–100)
1.60 ± 0.78
(1.47–1.79)
25.71 ± 5.34
(20.00–42.16)
Episodic migraine
plus ﬁbromyalgia
13  46.92 ± 8.64
(30–62)
71.08 ± 4.70
(65–80)
1.61 ± 0.55
(1.53–1.72)
27.33 ± 2.35
(23.87–30.86)
Chronic migraine
plus Fibromyalgia
20  44.30 ± 6.45
(31–57)
66.45 ± 12.39
(44–92)
1.61 ± 0.73
(1.50–1.76)
25.56 ± 4.16
(19.04–31.59)
SD, standard deviation; min, minimal; max, maximal.
a All cases were females.
Table 2 – Lactic acid levels at rest and the type of exercises phases.
Group Number of cases Rest (mmol/L)
Mean ± SD
Aerobic
(mmol/L)
Mean ± SD
Anaerobic
(mmol/L)
Mean ± SD
Rest post
exercise
(mmol/L)
Mean ± SD
Controls 20 2.39 ± 0.88 2.82 ± 2.41 3.64 ± 1.31 3.34 ± 1.24
Fibromyalgia 20 2.33 ± 1.08 2.38 ± 1.71 4.32 ± 1.96 3.37 ± 1.56
Episodic migraine 20 2.93 ± 1.38 3.22 ± 2.70 3.22 + 0.96 3.25 ± 1.39
Chronic migraine 20 2.79 ± 1.25 3.40 ± 1.91
p = 0.048a
4.21 ± 1.56 3.44 ± 1.19
Episodic migraine plus ﬁbromyalgia 13 2.40 ± 0.83 2.05 ± 0.81 4.15 ± 3.40 3.05 ± 1.60
Chronic migraine plus ﬁbromyalgia 20 3.23 ± 1.95 3.87 ± 2.53
p = 0.042a
3.43 ± 1.48 3.16 ± 1.27
rroniSD, standard deviation.
a Statistical signiﬁcance in relation to the control group before Bonfe
the phases of anaerobic exercise and rest after exercise phase.
In the aerobic phase we found that the levels of lactic acid
increased in the chronic migraine group (p = 0.048) and chronic
migraine plus ﬁbromyalgia group (p = 0.042) when compared
with the other groups. However, if we applied the Bonferroni
correction, this statistical signiﬁcance disappears (Table 2).
No patients with ﬁbromyalgia reported increased of muscle
pain in all phases of the exercise. All patients with migraine
and controls had no new complaints related tests during the
study.
Discussion
The lactic acid blood level increased during exercise, with
the skeletal muscle being the largest production site.20 The
increase in lactic acid production occurs after an increase
of glycogenolysis and glycolysis. These changes promote
a reversal of systemic genesis of energy, increasing circu-
lating levels of catecholamines and altering the systemic
glucose metabolism.21,22 The energy source in the central
nervous system (CNS) originates from glucose and lactic
acid. The latter serves as energy source after overcoming the Correction (Mann–Whitney U test).
blood–brain barrier or when being produced directly in glial
cells.23 In the CNS, lactic acid is essential for maintaining the
metabolic interactions between astrocytes and neurons, and
its increases in lactic acid inﬂuence neuronal activity in the
hypothalamus and the solitary tract.24,25
The diffusion of lactic acid is known to be mediated by
transporters, such as monocarboxylate transporters 1 (MCT1)
and 2 (MCT2), allowing greater ATP synthesis, closure of K
channels and neuronal depolarization.26 The sub-forms of
MCT1 and MCT2 are expressed in the sites of lactic acid
production (muscle and glial cells) and local of utilization
(astrocytes, blood vessels, hippocampus, cerebellum, cerebral
cortex and hypothalamus).27 In humans, the amount of intra-
cellular lactate is determined by the balance between the
amount produced in the cell from increased glycolysis (physi-
cal activity) and the quantity transported out of the cell or into
the mitochondria (inﬂuenced by MCT1). Acute physical activ-
ity alters the expression of MCT1 in the ﬁrst minutes, and this
change is maintained within 24 hours after exercise.28A central mechanism that may alter lactate removal is
the plasma volume (PV). Exercise is a potent inducer of PV
increase, which occurs immediately after the onset of phys-
ical activity. The increased PV also inﬂuences cardiovascular
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owever, the main removal capacity of lactate during exer-
ise is determined by the action of cellular MCT1, which is
xpressed in large amounts in the ﬁrst minutes following the
nset of physical activity. This relationship occurs such that
he increased amount of circulating MCT1 is directly related
o the reduction of the levels of muscle lactic acid.30,31
onclusion
n conclusion our groups of chronic migraine and chronic
igraine plus ﬁbromyalgia showed signiﬁcant increased lev-
ls of lactic acid during aerobic physical activity in relation to
he controls. However, they did not reach a statistical signiﬁ-
ance level after Bonferroni correction. The increased levels
eems to be more  dependent on the presence of chronic
igraine than ﬁbromyalgia and may be due to the increased
roduction, by the decreased metabolism of lactic acid or to
he several medications used by the patients. Our ﬁndings can-
ot support the suggestion of abnormal metabolism of lactic
cid in patients with episodic and chronic migraine associated
ith ﬁbromyalgia. No causal relationship between migraine,
bromyalgia and lactic acid production was found.
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